Aristeia Capital’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Aristeia Capital’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-223,135	Closed	-$17K	–	748
2022 Q2	$17K	Hold	223,135	–	–	﹤0.01%	646
2022 Q1	$34K	Hold	223,135	–	–	﹤0.01%	683
2021 Q4	$61K	Sell	223,135 -184,225	-45%	-$94.2K	﹤0.01%	596
2021 Q3	$291K	Buy	+407,360	New	+$307K	0.01%	443

Other funds holding CRXTW

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Aristeia Capital's CRXTW Position: Q3 2022 in Review

Aristeia Capital sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q3 2022, closing a stake of 223,135 shares — an estimated $17K sold.

Aristeia Capital first reported a position in CRXTW in Q3 2021 and held it in 4 quarters. The position peaked at $291K in Q3 2021. 5 funds tracked by Wall St. Rank hold CRXTW as of Q3 2022.

Aristeia Capital reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
Aristeia Capital sold 223,135 Clarus Therapeutics Holdings, Inc. Warrants shares in Q3 2022, an estimated $17K.
Aristeia Capital first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q3 2021 and held it in 4 quarters.
Aristeia Capital's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $291K in Q3 2021.
5 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q3 2022.

Based on Aristeia Capital's 13F filing for Q3 2022, filed 14 Nov 2022.